EMANATE - Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naive Patients with AF at ESC 2017

Afzal Sohaib met with Jens Cosedis Nielsen from Aarhus University Hospital, Aarhus, DK to discuss Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with Atrial Fibrillation Scheduled for Cardioversion (EMANATE) at ESC 2017.

Filmed by Radcliffe Cardiology on-site at ESC 2017.

Video Category: 

  • Atrial Fibrillation